Advertisement

Topics

Study sheds light on why some breast cancers have limited response to immunotherapy

20:00 EDT 20 Aug 2017 | AAAS

(UNC Lineberger Comprehensive Cancer Center) In the Journal of Clinical Investigation, UNC Lineberger Comprehensive Cancer Center researchers report on their study that explored a perplexing question: Why were drugs designed to unleash the immune system against cancer ineffective in a type of triple negative breast cancer with a heavy presence of immune cells? Their findings could lead to a strategy to improve immunotherapy responses in the 'claudin-low' subtype of breast cancer.

Original Article: Study sheds light on why some breast cancers have limited response to immunotherapy

NEXT ARTICLE

More From BioPortfolio on "Study sheds light on why some breast cancers have limited response to immunotherapy"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Breast Cancer
Track and monitor developments in breast cancer research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...